77 Biggest Movers From Yesterday

Author: Lisa Levin | July 21, 2020 04:34am

Gainers

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) gained 91.4% to close at $1.55 on Monday after jumping 27% in the previous session. Last Thursday, Tonix Pharmaceuticals reported a research collaboration to develop precision medicine techniques for coronavirus vaccines and therapeutics.
Majesco (NASDAQ:MJCO) shares jumped 72.3% to close at $13.16 after the company agreed to be acquired by Thoma Bravo for $13.10 per share.
iBio, Inc. (NYSE:IBIO) shares gained 63.9% to close at $6.41 after the company’s stock climbed almost 100% last week.
Immuron Limited (NASDAQ:IMRN) shares climbed 63.4% to close at $10.41 on Monday after guidance from the FDA cleared the way for two clinical studies in 2021 and will help the company with development of an investigational new drug application.
Just Energy Group Inc. (NYSE:JE) shares surged 52.5% to close at $0.54 after the company received an interim order from the Ontario Superior Court of Justice which grants a stay of proceedings for the company's recapitalization plan.
Heat Biologics, Inc. (NASDAQ:HTBX) gained 47.2% to close at $3.62 after climbing 25% on Friday.
Borqs Technologies Inc (NASDAQ:BRQS) gained 44.7% to close at $1.23 after the company said it expects delivery of 250,000 units in the fiscal year ending December 31, 2020.
DPW Holdings Inc (NYSE:DPW) shares gained 44.2% to close at $2.97 after the company reported it has released a product line of electric vehicle charges.
PDS Biotechnology Corporation (NASDAQ:PDSB) surged 39.2% to close at $4.19.
Onconova Therapeutics, Inc. (NASDAQ:ONTX) gained 34.1% to close at $1.09 following a 20% surge on Friday.
Akers Biosciences, Inc. (NASDAQ:AKER) surged 28.5% to close at $5.66.
AIM ImmunoTech Inc. (NYSE:AIM) shares rose 27.6% to close at $3.88.
INmune Bio, Inc. (NASDAQ:INMB) surged 26.3% to close at $14.08. INmune Bio reported a proposed public offering of common stock last week.
Daqo New Energy Corp. (NYSE:DQ) gained 25.2% to close at $111.11.
Arbutus Biopharma Corporation (NASDAQ:ABUS) surged 23.8% to close at $2.97.
Jumia Technologies AG (NYSE:JMIA) gained 22.3% to close at $9.33 amid strength in e-commerce and internet retail names.
Alexco Resource Corp. (NYSE:AXU) surged 21.8% to close at $3.07.
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) climbed 21.7% to close at $2.72.
Puhui Wealth Investment Management Co., Ltd. (NASDAQ:PHCF) rose 20.8% to close at $5.45.
Sorrento Therapeutics Inc (NASDAQ:SRNE) gained 19.9% to close at $8.36 after the company disclosed that it has received the FDA clearance to initiate a Phase 2 trial of Abivertinib in patients with Covid-19 who have moderate to severe pulmonary symptoms.
Molecular Data Inc. (NASDAQ:MKD) climbed 19.5% to close at $3.43.
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) rose 18.9% to close at $2.64 after gaining over 9% on Friday. Idera Pharmaceuticals last week announced a private placement of up to $20 million.
IMV Inc. (NASDAQ:IMV) rose 18.5% to close at $5.95. IMV appointed Michael P. Bailey to its Board of Directors.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) climbed 18.4% to close at $6.30.
GlobalSCAPE, Inc. (NYSE:GSB) gained 17.6% to close at $9.63. GlobalSCAPE and HelpSystems signed a merger agreement.
Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) shares surged 17.4% to close at $4.87.
360 Finance, Inc. (NASDAQ:QFIN) shares climbed 17.3% to close at $17.72 after peer Chinese fintech company, Ant Financial, filed for an IPO.
Lion Financial Group Limited (NASDAQ:LGHL) rose 17.3% to close at $5.55.
Hall of Fame Village, LLC (NASDAQ:HOFV) shares gained 16.9% to close at $6.54.
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) climbed 16.5% to close at $4.31.
Genocea Biosciences, Inc. (NASDAQ:GNCA)gained 16.3% to close at $2.4650. Genocea Biosciences is expected to share data on its GEN-009 trial on July 30th.
Altimmune, Inc. (NASDAQ:ALT) surged 16.1% to close at $33.26. On July 16, Altimmune reported closing of $132 million public offering of common stock and pre-funded warrants and full exercise of underwriters’ option.
Northern Dynasty Minerals Ltd. (NYSE:NAK) rose 16% to close at $1.96 after gaining around 13% on Friday. Northern Dynasty last week announced closing of $35.3 million bought deal.
Priority Technology Holdings, Inc. (NASDAQ:PRTH) gained 16% to close at $2.54.
Ayro, Inc. (NASDAQ:AYRO) climbed 15.9% to close at $5.10.
Fortress Biotech, Inc. (NASDAQ:FBIO) surged 15.7% to close at $3.32.
NIO Inc. (NYSE:NIO) shares rose 15.6% to close at $12.82 after peer Chinese electric vehicle company Xpeng raised $500 million ahead of a reported IPO.
AIkido Pharma Inc. (NASDAQ:AIKI) gained 15.5% to close at $1.19 after climbing about 10% on Friday.
Big 5 Sporting Goods Corporation (NASDAQ:BGFV) surged 15.3% to close at $3.62. Big 5 Sporting Goods issued preliminary Q2 guidance earlier this month.
BioXcel Therapeutics Inc (NASDAQ:BTAI) rose 14.1% to close at $60.42 as the company disclosed that BXCL501 met the primary and secondary endpoints in two pivotal Phase 3 trials.
Denbury Resources Inc. (NYSE:DNR) shares rose 12.3% to close at $0.2554 following a report suggesting the company is evaluating an acquisition proposal at $1.20 per share.
Novan, Inc. (NASDAQ:NOVN) climbed 12.2% to close at $0.69.
Forum Energy Technologies, Inc. (NYSE:FET) shares rose 12.2% to close at $0.4736. Forum Energy Technologies last week said it projects preliminary Q2 sales of $110 million to $115 million.
Eros International plc (NYSE:EROS) climbed 11.5% to close at $3.68 after the company announced its app would be pre-installed on select Sony smart TVs in India.
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shares rose 10.9% to close at $2.45.
Bionano Genomics, Inc. (NASDAQ:BNGO) climbed 10.8% to close at $0.6847 after climbing around 19% on Friday.
Assembly Biosciences Inc (NASDAQ:ASMB) climbed 10.5% to close at $27.04 after the company disclosed that it has granted BeiGene rights to develop and commercialize its clinical-stage inhibitors for Hepatitis B in China.
Ceragon Networks Ltd. (NASDAQ:CRNT) gained 10.3% to close at $2.67.
Rosetta Stone Inc (NYSE:RST) climbed 6% to close at $21.22 following Friday reports that the company hired an advisor to explore the sale of the company.
Noble Energy, Inc. (NASDAQ:NBL) rose 5.4% to close at $10.18 after the company agreed to be acquired by Chevron Corporation (NYSE:CVX) for $10.38 per share.
Koninklijke Philips NV (NYSE:PHG) climbed 4.7% to close at $52.10 after the company reported upbeat Q2 results.
ContraFect Corporation (NASDAQ:CFRX) gained 4.6% to close at $6.41 after the company reported up to $18.9m in funding from CARB-X to support acceleration of CF-370 program for treating pseudomonas aeruginosa infections towards clinical stage development.
Churchill Capital Corp II (NYSE:CCX) rose 4.3% to close at $11.50 after Bloomberg reported that Topgolf is in talks to go public via Churchill Capital Corp. II.
BioNTech SE – ADR (NASDAQ:BNTX) gained 3.5% to close at $88.20. Pfizer Inc (NYSE:PFE) and BioNTech reported an agreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2.

Check out these big penny stock gainers and losers

Losers

YRC Worldwide Inc. (NASDAQ:YRCW) shares dropped 27.2% to close at $2.60 on Monday. The Bipartisan Panel raised questions about Treasury Departments’ decision to designate the company as critical to national security and lend it $700 million in coronavirus-relief fund.
CBL & Associates Properties, Inc. (NYSE:CBL) shares fell 24.2% to close at $0.1859 on Monday following an 11% decline on Friday.
Genetic Technologies Limited (NASDAQ:GENE) shares dipped 24% to close at $4.31 on Monday. On Thursday, Genetic Technologies priced a 1.025 million ADS offering at $5 per ADS.
Nikola Corporation (NASDAQ:NKLA) declined 21.3% to close at $38.45 after the company disclosed a common stock offering.
Boxlight Corporation (NASDAQ:BOXL) fell 20.4% to close at $2.92 after declining around 13% on Friday. Boxlight’s website discussed collaboration with Samsung last week.
SenesTech, Inc. (NASDAQ:SNES) dropped 19.7% to close at $2.00.
PetMed Express, Inc. (NASDAQ:PETS) fell 17.7% to close at $33.36 after reporting earnings for the first quarter.
RumbleON, Inc. (NASDAQ:RMBL) fell 16.2% to close at $21.51. RumbleON shares surged over 139% on Friday after the company announced a dealer-centric pilot program with CarGurus.
Houghton Mifflin Harcourt Company (NASDAQ:HMHC) dropped 15.7% to close at $2.36 after gaining 19% on Friday. On Friday, Houghton Mifflin Harcourt responded to 'false rumors' on Twitter regarding new sales contracts.
WiMi Hologram Cloud Inc. (NASDAQ:WIMI) dropped 15.3% to close at $13.80.
Daxor Corporation (NYSE:DXR) fell 15.3% to close at $20.14 after the company reported the pricing of a $7 million common stock offering.
The Peck Company Holdings, Inc. (NASDAQ:PECK) shares fell 14.5% to close at $3.89.
I-Mab (NASDAQ:IMAB) fell 13.5% to close at $28.55. I-Mab, last week, reported authorization of up to $20 million buyback.
Sphere 3D Corp. (NASDAQ:ANY) shares declined 13.4% to close at $2.98. ROK Consulting disclosed a 6.78% stake in the company last week.
Barnes & Noble Education, Inc. (NYSE:BNED) dropped 12.8% to close at $2.19.
Moderna, Inc. (NASDAQ:MRNA) fell 12.8% to close at $82.68 after early results of AstraZeneca & Oxford University's coronavirus vaccine were released.
Ashford Hospitality Trust, Inc. (NYSE:AHT) declined 12.6% to close at $6.06.
Moderna Inc (NASDAQ:MRNA) fell 11.8% to close at $2.39 after a paper surfaced that allegedly showed Pfizer & BioNtech's vaccine candidate, BNT162b1, gives a stronger T-cell response than Moderna's vaccine candidate.
MicroVision, Inc. (NASDAQ:MVIS) dropped 10.5% to $2.4250.
AC Immune SA (NASDAQ:ACIU) dropped 10.1% to close at $7.44. AC Immune last week announced it has advanced its phospho-tau Alzheimer's vaccine in its phase 1b/2a study.
Color Star Technology Co Ltd (NASDAQ:HHT) fell 8.6% to close at $1.59 after the company announced a $4.2 million common stock offering.
PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) shares fell 8% to close at $5.05. On Friday, PhaseBio announced it dosed the first patient in VANGUARD, a Phase 2 clinical trial evaluating PB1046 as a treatment for Covid-19 patients.
Verona Pharma plc (NASDAQ:VRNA) fell 7.2% to close at $9.47. Verona Pharma shares climbed 112% on Friday after the company announced it raised $200 million in a private placement at $4.50 per share.